Clinical Trials on Nevi and Melanomas in Canada
Total 26869 results
-
AHS Cancer Control AlbertaTransplant Genomics, Inc.Unknown
-
Wilson MillerActive, not recruitingMetastatic Malignant MelanomaCanada
-
Jewish General HospitalActive, not recruitingUntreated Stage III Melanoma or Stage IV MelanomaCanada
-
Canadian Cancer Trials GroupMerck Sharp & Dohme LLCTerminated
-
University Health Network, TorontoCompletedMetastatic, Stage III or Stage IV, MelanomaCanada
-
Threshold PharmaceuticalsTerminatedMetastatic MelanomaUnited States, Canada
-
University Health Network, TorontoCompleted
-
University Health Network, TorontoRecruitingCutaneous Melanoma | Mucosal Melanoma | Melanoma Stage IVCanada
-
Lawson Health Research InstituteActive, not recruiting
-
Hoffmann-La RocheCompletedUveal Melanoma | Cutaneous Melanoma | Mucosal MelanomaSpain, United States, Belgium, Denmark, Canada, Australia
-
Sunnybrook Health Sciences CentreTerry Fox Research InstituteRecruiting
-
NCIC Clinical Trials GroupNational Cancer Institute (NCI)CompletedMelanoma (Skin)Canada
-
University Health Network, TorontoCompletedPreviously Untreated and Histologically Confirmed Stage III (Unresectable) or Stage IV MelanomaCanada
-
Hoffmann-La RocheCompletedMalignant Melanoma, NeoplasmsKorea, Republic of, Brazil, United States, Canada, Cyprus
-
Grupo Español Multidisciplinar de MelanomaGlaxoSmithKlineCompletedMalignant Melanoma Stage IV | Malignant Melanoma Stage IIIcSpain
-
Bristol-Myers SquibbMedarexCompletedMalignant MelanomaUnited States, Peru, Canada, Israel, Italy, United Kingdom
-
NCIC Clinical Trials GroupZymoGeneticsCompletedMelanoma (Skin)Canada
-
NCIC Clinical Trials GroupNational Cancer Institute (NCI)CompletedMelanoma (Skin)Canada
-
National Cancer Institute (NCI)CompletedIntraocular Melanoma | Recurrent Melanoma | Stage IV Melanoma | Ciliary Body and Choroid Melanoma, Medium/Large Size | Ciliary Body and Choroid Melanoma, Small Size | Iris Melanoma | Extraocular Extension Melanoma | Acral Lentiginous Malignant Melanoma | Lentigo Maligna Malignant Melanoma | Superficial... and other conditionsCanada
-
University Health Network, TorontoNot yet recruiting
-
Carman GiacomantonioNova Scotia Health AuthorityTerminatedMelanoma (Skin) | Melanoma in SituCanada
-
AHS Cancer Control AlbertaCompleted
-
Hoffmann-La RocheCompletedMetastatic MelanomaUnited States, Canada, Belgium, Spain, France, Russian Federation, Australia
-
National Cancer Institute (NCI)CompletedRecurrent Melanoma | Stage IV Melanoma | Uveal Melanoma | Ciliary Body and Choroid Melanoma, Medium/Large Size | Iris Melanoma | Recurrent Intraocular Melanoma | Extraocular Extension MelanomaCanada, United States
-
IDEAYA BiosciencesRecruitingColorectal Cancer | Metastatic Uveal Melanoma | Cutaneous Melanoma | Other Solid TumorsUnited States, Australia, Canada
-
NCIC Clinical Trials GroupCompleted
-
Grupo Español Multidisciplinar de MelanomaCompleted
-
Array BioPharmaTerminatedLocally Advanced Metastatic BRAF Mutant MelanomaAustralia, Canada, Netherlands, United States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Completed
-
Canadian Cancer Trials GroupMelanoma and Skin Cancer Trials LimitedRecruitingUnresectable/Metastatic MelanomaCanada, Australia
-
Astellas Pharma IncCompletedMelanomaUnited States, Canada
-
University Health Network, TorontoMerck Sharp & Dohme LLCCompletedAdvanced Ovarian Cancer | Malignant MelanomaCanada
-
PfizerPierre Fabre LaboratoriesActive, not recruitingAdvanced Solid Tumors | Metastatic MelanomaUnited States, Spain, Belgium, Canada, Netherlands
-
Bristol-Myers SquibbNo longer availableMalignant MelanomaUnited States, Canada
-
AstraZenecaCompletedRefractory MelanomaUnited States, Spain, Canada, France, Italy, United Kingdom, Argentina, Australia, Germany
-
Merck Sharp & Dohme LLCEisai Inc.CompletedAdvanced MelanomaCanada, United States, Australia, Spain, Sweden
-
CancerVax CorporationUnknownMalignant MelanomaUnited States, France, Australia, Canada, Germany, United Kingdom, Switzerland, Brazil, Ireland, Israel, Italy, Netherlands, New Zealand
-
CancerVax CorporationUnknownMalignant MelanomaUnited States, France, Australia, Canada, Germany, Switzerland, Brazil, Ireland, Israel, Italy, Netherlands, New Zealand, United Kingdom
-
Hoffmann-La RocheCompletedMalignant MelanomaFrance, Germany, Italy, Sweden, United States, Australia, Canada, United Kingdom, Netherlands, Switzerland, New Zealand, Israel
-
MedImmune LLCCompletedMelanomaItaly, United States, Canada, France
-
Hoffmann-La RocheCompletedMalignant MelanomaCanada, Spain, United Kingdom, Hungary, Australia, Austria, Belgium, Ecuador, Estonia, Finland, Ireland, Italy, Korea, Republic of, Mexico, Netherlands, Portugal, Slovenia, Sweden, Turkey, Brazil, India, Germany, Bosnia and Herzegovina and more
-
Grupo Español Multidisciplinar de MelanomaRecruitingAdvanced Cancer | Melanoma Stage Iv | Melanoma Stage IiiSpain
-
Philogen S.p.A.RecruitingMelanoma Stage IIIB/CSpain, United States, Switzerland
-
OncoSec Medical IncorporatedMerck Sharp & Dohme LLCActive, not recruitingStage III/IV MelanomaUnited States, Australia, Canada, Italy, Switzerland
-
Bristol-Myers SquibbCompletedAdvanced Cutaneous MelanomaGermany, Poland, Spain, Australia, France, Argentina, Ireland, Israel, Belgium, United States, Switzerland, United Kingdom, Greece, Austria, Canada
-
AmgenCompletedMelanomaUnited States, Canada
-
Grupo Español Multidisciplinar de MelanomaRoche Farma, S.A; Pivotal S.L.Completed
-
CelgeneUniversity of ArizonaCompletedMalignant MelanomaCanada, United States, Australia, United Kingdom, France, Italy, Spain, Germany, Netherlands
-
Maxim PharmaceuticalsNational Cancer Institute (NCI)UnknownMetastatic Cancer | Melanoma (Skin)United States, Canada, Germany, United Kingdom